Fate Therapeutics (FATE) Presents At 2019 ASH Annual Meeting - Slideshow

Better Cells For Better Therapies™ | --- | --- | |-----------------------------------------------------------------------|-------| | | | | Off-the-shelf Cell-based Cancer Immunotherapy | | | Developing First-of-kind Cell Products using Clonal Master iPSC Lines | | | 2019 ASH Dinner Discussion | | | December 6, 2019 | | - Jeffrey S. Miller, MD Cells For Better Therapies TM Deputy Director, Masonic Cancer Center Director, Cancer Experimental Therapeutics Join Us for Dinner Initiative (CETI), University of Min ...